FDMT 4D Molecular Therapeutics Inc.
FDA Catalyst Company
8.17
-0.29 -3%
Previous Close
8.46
Open
8.76
52 Week Low
8.42
52 Week High
36.14
Market Cap
$263,380,342
Shares
32,237,496
Float
25,809,750
Enterprise Value
$59,130,838
Volume
81,120
Av. Daily Volume
194,021
Live cash est
$88,666,444,222
Cash Burn
N/A
No. Mths Cash
12
Insiders %
0.2
Total debt to equity
4.35
Earnings Date
01/01/2001
EPS EST.
1.82
EPS PRIOR.
1.82
EPS
1.82
Rev guidance
$10,459,000,000
Biotech Analyst Ratings
Analyst | Action | Rating Now | PT Prior | PT Now | Last Updated |
---|---|---|---|---|---|
SVB Leerink | Premium membership is required to view catalyst dates, analyst ratings, earnings dates and cash burn data. Click here to unlock and sign up to a 30 day FREE TRIAL. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | 05/13/2022 |
SVB Leerink | Premium membership is required to view catalyst dates, analyst ratings, earnings dates and cash burn data. Click here to unlock and sign up to a 30 day FREE TRIAL. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | 01/04/2022 |
B of A Securities | Premium membership is required to view catalyst dates, analyst ratings, earnings dates and cash burn data. Click here to unlock and sign up to a 30 day FREE TRIAL. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | 01/05/2021 |
Goldman Sachs | Premium membership is required to view catalyst dates, analyst ratings, earnings dates and cash burn data. Click here to unlock and sign up to a 30 day FREE TRIAL. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | 01/05/2021 |